Updated:
Novocardia
Novocardia was formed to equip cardiology practices with the infrastructure needed to succeed under value-based reimbursement.
Novocardia
Novocardia was formed to equip cardiology practices with the infrastructure needed to succeed under value-based reimbursement. It serves as the care-delivery and analytics arm of Cardiovascular Associates of America, a nationwide cardiovascular network. The model targets chronic cardiovascular disease management through integrated programs that span longitudinal heart failure care, site-of-service optimization, and care-transitions intervention. The strategy combines direct clinical operations with a technology stack built for risk-bearing contracts. Its platform ingests electronic health record and payer claims data to power risk-stratification modeling, remote patient monitoring, and purpose-built actuarial analysis. Confirmed programs include a longitudinal heart failure initiative and same-day access protocols. The geographic footprint covers practices across multiple US states, with a payer partnership network that includes Humana, through a value-based care agreement focused on Medicare Advantage members announced in 2025 (per firm website, 2025). The arrangement ties reimbursement to reductions in cost of care and improvements in clinical outcomes, specifically targeting avoidable ER visits and cardiology-related readmissions. Novocardia reports a 46% reduction in emergency room visits and a 43% decrease in cardiology-related re-admissions across its network, alongside appointment access that it states is up to four times faster than the national average. The firm operates within the broader CVAUSA network — CVAUSA’s website describes the combined entity as the largest cardiovascular care network in the country. In 2025, Novocardia Care Solutions formalized a multi-state value-based care agreement with Humana to manage cardiovascular care for eligible Humana Medicare Advantage members (per firm website, 2025). Novocardia’s architecture is distinct because it layers a centralized value-based contracting entity on top of a distributed network of independent physician practices. Rather than employing cardiologists directly, it partners with practices and supplies the analytics, care-model design, and payer-contracting infrastructure — allowing physicians to retain local autonomy while shifting toward shared-risk reimbursement. This intermediary structure sits between fee-for-service cardiology and fully-capitated provider groups, and its success depends on continued payer appetite for condition-specific, specialty-led risk arrangements.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Waltham
Corporate office
Waltham, MA, United States
Sector focus
Frequently asked questions
How is Novocardia related to Cardiovascular Associates of America (CVAUSA)?
Novocardia is the dedicated value-based care division of CVAUSA. Following a merger of the two organizations, Novocardia now functions as the entity through which CVAUSA’s national network of cardiologists engages in risk-bearing contracts with payers. It supplies the care-model design, proprietary analytics, and contracting infrastructure while CVAUSA maintains the broader physician-network and practice-management relationship.
What specific results has Novocardia reported from its care model?
Across its network, Novocardia reports a 46% reduction in emergency room visits and a 43% reduction in cardiology-related hospital re-admissions compared to national averages. It also cites a 28% lower regional cost of care and appointment access up to four times faster than the national benchmark. These figures appear on the firm’s website and are attributed to its risk-stratification tools, same-day access protocols, and longitudinal heart failure management program.
How does Novocardia interface with payers like Humana?
Novocardia Care Solutions enters into multi-state value-based care agreements directly with insurers. In 2025, it announced a partnership with Humana covering eligible Medicare Advantage plan members. Under these arrangements, Novocardia assumes responsibility for managing cardiovascular cost and quality — targeting reductions in avoidable hospitalizations and ER visits — and both parties share performance data to drive ongoing care-quality improvements.
Does Novocardia employ its physician partners or operate as a management services organization?
Novocardia partners with independent cardiology practices rather than employing physicians directly. It provides the analytics platform, clinical program design, and payer-contracting capabilities that allow those practices to participate in value-based reimbursement. The practices maintain clinical autonomy while Novocardia and CVAUSA supply the infrastructure needed for risk-bearing contracts.
What technology or analytics capabilities does Novocardia use to manage risk?
Novocardia’s platform integrates electronic health record data and payer claims to feed risk-stratification models that track utilization, outcomes, and cost. It also deploys remote patient monitoring for vital signs and patient-reported outcomes, alongside purpose-built actuarial models intended to forecast cost dynamics. The firm describes these tools as proprietary, distinguishing its approach from practices that rely solely on standard EHR reporting.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: